The Nomination Committee of Elekta AB has now been appointed in accordance with the AGM resolutions.
AP4 is represented by Per Colleen, Head of Equities.
The other members in the committee is:
- Laurent Leksell, Chairman of the Board of Elekta
- Åsa Nisell, Swedbank Robur funds
- Magnus Henjeby, Nordea Investments funds
- Tomas Flodén, AMF Försäkring & Fonder
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Today, Elekta solutions in oncology and neurosurgery are used in over 6 000 hospitals worldwide. The corporate headquarters are located in Stockholm, and the company is listed on NASDAQ Stockholm.